Construction crews will fix NYC’s buckled former Pfizer building by lifting sagging floors 1/64th of an inch at a time up to ...

The dividend is probably the reason investors hold Pfizer (PFE), the maker of medicines such as Eliquis and Padcev. The stock ...

$3,600,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. This ...

In the latest trading session, Pfizer (PFE) closed at $30.11, marking a +2.28% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.28%. Meanwhile, the ...

This article is a personal record by the author (me) and does not recommend buying or selling any specific stocks. Figures ...

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for ...

Pfizer Inc. (ISIN US7170811035) was trading at EUR 26.39 at Lang & Schwarz on October 20, 2026, 1.03 percent above the Xetra ...

A rotation out of artificial-intelligence-driven tech names into higher-yielding, defensive healthcare stocks is gathering ...

This is a small sample size, of course, but it may be the start of a new trend emerging, with investors pivoting to safer stocks that offer high yields. The healthcare sector is full of them, with ...

Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash ...

Scott Gottlieb, the Food and Drug Administration commissioner turned Pfizer director and prominent critic of Robert Kennedy ...

Work to repair a high-rise building at the corner of East 42nd Street and Second Avenue is set to begin. During the summer, ...